Zakrzewski Joseph S 的 Form 4/A 修正申報
修正Cyteir Therapeutics, Inc.（CYT），2022/12/8 申報
- 申報編號
- 0001209191-22-060431
- 申報時間
- 2022/12/8
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/12/8
這份申報沒有列出任何交易。沿用原件裡沒有重述的 1 筆交易。公開市場買進合計 $2.76 萬。
這份修正申報重述了 0001209191-22-060377（2022/12/8 申報）的一部分，沒有重述的交易仍然有效，列在下面。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Zakrzewski Joseph SCIK 0001331852 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
這份申報沒有這一類的交易。
沿用原件的交易
這份修正申報只重述了原件的一部分。原件其他的交易仍然有效，網站的交易表把它們算在這份修正申報底下。
來自 0001209191-22-060377（2022/12/8 申報）。
非衍生性證券（表 I）
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/7 | Common Stock | P買進取得 | +21,202 | $1.30F1 | +$27,562.6 | 154,618 | 直接 |
原件的附註
這幾筆交易的價格在原件上引用的附註。
- F1
The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $1.28 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
表 I 有 1 筆交易的價格引用這則附註。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The original Form 4 filed on December 8, 2022 reported securities in column 5 of Table I as indirectly beneficially owned by the Reporting Person through Z Investments, LLC, but these securities were previously transferred to the Reporting Person and should have been reported as directly beneficially owned by the Reporting Person.
- F2
27,551 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
- F3
Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
備註
As noted in Footnote 1, this Form 4/A amends the Form 4 filed on December 8, 2022 for this Reporting Person.